Masataka Sunagawa
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 7
-
- Natural Compounds in Disease Treatment 10
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 10
- Antibiotics Pharmacokinetics and Efficacy 10
- Alkaloids: synthesis and pharmacology 9
- Healthcare and Venom Research 8
- Plant-based Medicinal Research 7
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 10
- Antibiotics Pharmacokinetics and Efficacy 10
- Alkaloids: synthesis and pharmacology 9
- Healthcare and Venom Research 8
- Plant-based Medicinal Research 7
- Biological Psychiatry top 10%
-
- Pain Mechanisms and Treatments 9
- Co-authors
- Tadashi HisamitsuYanqing LiuHideaki MatsumuraShiyu GuoYoshihiro SumitaGuoqing LiYayun QianShintaro Ishikawa
- Journals
- Cell (1 paper)SHILAP Revista de lepidopterología (5 papers)Antimicrobial Agents and Chemotherapy (1 paper)
In The Last Decade
Masataka Sunagawa
99 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 115
- Molecular Medicine 118
- Complementary and alternative medicine 153
- Pharmacology 299
- Pharmacology 144
- Biological Psychiatry 37
Countries citing papers authored by Masataka Sunagawa
This map shows the geographic impact of Masataka Sunagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Sunagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Sunagawa more than expected).
Fields of papers citing papers by Masataka Sunagawa
This network shows the impact of papers produced by Masataka Sunagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Sunagawa. The network helps show where Masataka Sunagawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masataka Sunagawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2021 | 15 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 117 | |
| 11 | 2018 | 22 | |
| 12 | 2017 | 27 | |
| 13 | 2016 | 18 | |
| 14 | 2015 | 6 | |
| 15 | KAMPO MEDICINE "DAIKENCHUTO" PREVENTS THE DECREASE OF INTERSTITIAL CELLS OF CAJAL IN MICE WITH CONSTIPATION INDUCED BY MORPHINE | 2015 | 0 |
| 16 | EBM of Kampo medicine in oral surgery | 2015 | 5 |
| 17 | 2014 | 19 | |
| 18 | 2011 | 8 | |
| 19 | 1997 | 4 | |
| 20 | Separation of large DNA molecules from Pleurotus cornucopiae by pulsed-field gel electrophoresis | 1995 | 4 |
About Masataka Sunagawa
Masataka Sunagawa is a scholar working on Complementary and alternative medicine, Pharmacology and Molecular Medicine, having authored 107 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (10 papers), Natural Compounds in Disease Treatment (10 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Alkaloids: synthesis and pharmacology (9 papers), Pain Mechanisms and Treatments (9 papers), Healthcare and Venom Research (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Plant-based Medicinal Research (7 papers). The work is most often cited by research in Molecular Medicine (118 citations), Complementary and alternative medicine (153 citations) and Pharmacology (299 citations). Masataka Sunagawa has collaborated with scholars based in Japan, China and Algeria. Frequent co-authors include Tadashi Hisamitsu, Yanqing Liu, Hideaki Matsumura, Shiyu Guo, Yoshihiro Sumita, Guoqing Li, Yayun Qian, Shintaro Ishikawa, Yasunori Takayama and Kenta Maruyama. Their work appears in journals such as Cell, SHILAP Revista de lepidopterología and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.